ABSTRACT
INTRODUCTION
Poxviruses have proven to be a reliable and versatile mammalian gene expression system allowing for multiple applications including vaccine design, immunological studies and posttranslational modification analyses (8, 12, 13, 18) . Most recombination systems rely on positive and/or negative selectable markers engineered into the viral insertion vectors and particular cell lines for utilizing those markers (3, 4, 6, 10) . Alternatively, protocols have been developed that do not rely on the incorporation of selectable markers; they rely instead on plaque phenotype for selection (1) . Various strategies have emerged to streamline the recombination of desired genetic material with the poxvirus genome and the tedious isolation of recombinant viruses (3, 4, 6, 10, 11, 15, 16, 20) . While these insertion vectors are convenient, there are several situations for limiting their use: (i) incorporation of selectable markers into insertion vectors produces larger plasmids that result in more cumbersome DNA manipulations; (ii)use of certain selectable markers requires targeting the insertion vector to particular poxvirus genes (such as thymidine kinase) and renders potential viral virulence factors inactive, which may reduce the desired immunological impact; (iii)certain selectable markers may require the use of specialized cell lines for recovery of recombinants; and (iv) incorporation of selectable markers will add potential antigens to an antigen expression vehicle that may prove undesirable for immunological analyses or vaccination protocols.
Guanine phosphoribosyl transferase ( gpt ) has proven to be a reliable and convenient selectable marker for use in a wide variety of cell lines for poxvirus recombination (2, 5, 6, 9) . Gpt selection during transfection can increase the percentage of recombinant viruses among viral progeny (2). The method described below differs from a previous report (6) by utilizing gpt on a separate independent plasmid under the control of a vaccinia virus (VV) early/late promoter (P7.5) that is incapable of recombination into the viral genome. In addition, integration of the selectable marker is not required at all during the process, and a specialized insertion vector is not needed (6) . With this feature, selection is used only once by pretreating cells before transfection and is maintained throughout the recombination step. Following harvest, progeny virus can be plated on any cell type permissive for the desired recombinant virus. The enrichment of recombinant virus has been demonstrated to be sevenfold using two different VV insertion vectors that have different efficiencies for recombination.
MATERIALS AND METHODS
CV-1 (Catalog No. CCL70; ATCC, Rockville, MD, USA) and TK -143B (Catalog No. CRL8303; ATCC) cell lines were maintained in minimum essential medium (MEM) with 10% fetal bovine serum (FBS) at 37°C in 5% CO 2 . VV strain WR was used throughout, and viral infections were maintained in MEM with 5% FBS with similar incubation conditions as for cell lines. Insertion vectors pSC11 (3) and pCF11 (7) were used for transfections. pSC11 places a gene under the control of the VV early/late promoter P7.5, inserts into and inactivates the VV tk gene, and provides a visual marker with β -galactosidase ( β -gal) under control of the VV P11 promoter (3). pCF11 places a gene under control of the VV P7.5 promoter, inserts into the Hin dIII C region and only provides for visual identification by expression of β -gal (7).
The gptgene was isolated from by excising the coding region with Hin dIII and Xba I, resulting in a 600-bp fragment. After repair of the ends with T4 DNA Polymerase (New England Biolabs, Beverly, MA, USA), the fragment was ligated into the Sma I site of pSC11. Following selection of a plasmid (pSC:7.5gpt) with the correct orientation ( gpt relative to the P7.5 promoter), the P7.5-gpt region was excised with Xba I and Eco RI (ca. 950 bp), the ends repaired as above, and ligated into the Hin cII site of pBS. The resulting plasmid is denoted as pBS:VVPgpt.
VV recombination was performed according to standard protocols (11, 14) . Pretreatment of CV-1 cells with mycophenolic acid (MPA) before transfection was performed as described, except that FBS was maintained at 5% (5) . Under these conditions, recombination of various insertion vectors carrying gpt selectable markers has been achieved with ease (unpublished results). CV-1 cells were pretreated overnight (up to 24 h) before transfection with selection media (MEM with 5% FBS containing 25 µ g/mL MPA, 250 µ g/mL xanthine and 15 µ g/mL hypoxanthine) in nearly confluent 25-cm 2 flasks. The pretreated cells were infected at a multiplicity of infection (MOI) Step A refers to gpt fragment isolation followed by repair of the ends.
Step B refers to gpt fragment ligation into pSC11.
Step C refers to P7.5: gpt fragment isolation with repair of the ends.
Step D refers P7.5: gpt fragment into pBS.
RESULTS AND DISCUSSION
Construction of gpt under the control of a VV promoter proceeded as outlined in Figure 1 . To test for activity of the VV-regulated gptgene, the pSC7.5:gpt plasmid was recombined into VV without selection and isolated by negative selection against tk activity. Recombinants were then identified by β -gal positive plaques. Those plaques were subsequently tested for the ability to grow in the presence of MPA and compared to wild-type VV. Viral recombinants obtained in this manner did indeed grow under selection, while wild-type VV did not (data not shown), indicating that the P7.5-gpt construction was indeed functional and capable of mediating viral growth in the presence of MPA.
To test for recombinant enhancement of gpt selection during transfection, 20 µ g of pBS:VVPgpt were mixed with either 20 µ g of pSC11 or pCF11 in a total volume of 2.0 mL and precipitated by CaPO 4 for 30 min before overlaying VV-infected cells with 0.8 mL of the precipitated DNA. The precipitated DNA was overlaid onto CV-1 cells that had either received MPA pretreatment or received mock pretreatment (MEM with 5% FBS). After transfection, the virus was harvested and titered on TK -143B and analyzed for the presence of recombinant virus by β -gal activity. In the case of pSC11, total viral titers were determined in the absence of bromodeoxyuridine (BrdU), while recombinant viral titers were evaluated in the presence of BrdU (25 µ g/mL). The viral harvest was also tested for nonhomologous incorporation of the gpt marker by selection in the presence of MPA. No evidence of nonhomologous recombination was identified (data not shown). Table 1 shows a representative experiment. Clearly, the MPA treatment has a definite effect on the quantity of progeny virus with 94.7%-98.5% reduction in the total virus produced in the presence of MPA. Recombinant virus production is also reduced by 57.5%-89.1% to ninefold in MPA(+) vs. MPA(-). However when recombinant titers are expressed as percentages of total virus, the frequency of recombinant viruses is seen to increase by at least sevenfold for each insertion vector. This is even apparent over the range of insertion efficiencies. pSC11 is observed to produce about 0.011% recombinant viruses, while pCF11 is more efficient at 0.092%. The differences in recombination frequencies may be due to differences in genome insertion points or insertion vector sizes, although subtle differences in transfected DNA preparation cannot be excluded. Total virus production with both insertion vectors was similar (within twofold) and thus, did not appear to influence virus replication significantly.
In spite of the range of recombination efficiency, MPA selection during transfection was able to increase recombination efficiency by approximately the same amount for both vectors (pSC11-7.7-fold vs. pCF11-7.3-fold). This would argue for a vector-independent mechanism and would likely be useful with even inefficient insertion vectors. The mechanism for unlinked selection is likely to involve the propensity of the minority of cells that take up CaPO 4 -precipitated DNA to take in a large amount of DNA (multiple copies of plasmid). Thus, cells that take up one plasmid are more likely to take up another independent plasmid. Previous work has shown at least 25% of cells that expressed transfected DNA will take in two different plasmids during co-transfection in spite of the small fraction of cells expressing either plasmid DNA (19) . While the requirements for gene expression may be more restrictive than simply for DNA uptake by cells, these data argue strongly in favor of a mechanism whereby multiple copies of plasmid DNA are taken in by a given cell. In the case of VV-infected cells, only the cells that take up the pBS:VVPgpt plasmid will be able to grow in the presence of MPA. Since those cells are also more likely to also take up the insertion vector as well, recombination into the viral genome can also occur in cells able to overcome gpt selection. Cells that receive neither plasmid would not be capable of a productive infection. Thus, MPA selection can limit viral replication to the minority of cells that have actually been transfected and reduce the background wildtype virus generation going on in the vast majority of untransfected but VVinfected cells.
While for many VV insertion vectors the improvement the recombination frequency is not a necessary step for isolation of viral recombinants, for certain vectors, this protocol has definite utility. pCF11 is one such vector that clearly benefits. Without gpt selection, visual screening with β -gal would require several thousand plaques be plated, while gpt selection reduces that figure to several hundred. Another VV insertion vector, p1200 (17) , inserts into the VV tk gene; however, without a visual marker, multiple tk -plaques must be isolated and characterized. Since p1200 is already 8.3 kbp, incorporation of a selectable marker is not desirable. Utilization of this protocol with p1200 results in >90% of isolated plaques (the tk -population) being characterized as recombinant virus (data not shown).
In summary, gpt selection using an unlinked gpt selectable plasmid can result in a significant increase in recombinant VV generation efficiency. Because the plasmid is separate from the VV insertion vector, the recombinant enrichment is vector-independent and broadly applicable for insertion to any region of the poxvirus genome. Other forms of selection are still feasible to further increase yield. In fact, with only a change in promoters, this approach should be applicable to any system where transfection is utilized to generate viral recombinants.
